Cargando…
Aprepitant Inhibits JNK and p38/MAPK to Attenuate Inflammation and Suppresses Inflammatory Pain
Substance P contributes to the pathogenesis of pain by acting on NK-1R, specialized sensory neurons that detect noxious stimuli. Aprepitant, an antagonist of NK-1R, is widely used to treat chemotherapy-induced nausea and vomiting. In this study, we used LPS-stimulated BV-2 microglia cell line and an...
Autores principales: | Yang, Yang, Zhou, Wei, Xu, Xiuqi, Ge, Xianxiu, Wang, Fei, Zhang, Guang-Qin, Miao, Lin, Deng, Xueting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786910/ https://www.ncbi.nlm.nih.gov/pubmed/35087409 http://dx.doi.org/10.3389/fphar.2021.811584 |
Ejemplares similares
-
Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation
por: Cao, Xueyan, et al.
Publicado: (2023) -
Ginsenoside Compound K Attenuates Ox-LDL-Mediated Macrophage Inflammation and Foam Cell Formation via Autophagy Induction and Modulating NF-κB, p38, and JNK MAPK Signaling
por: Lu, Shan, et al.
Publicado: (2020) -
SGLT1 Inhibition Attenuates Apoptosis in Diabetic Cardiomyopathy via the JNK and p38 Pathway
por: Lin, Na, et al.
Publicado: (2021) -
Kaempferol Ameliorates the Inhibitory Activity of Dexamethasone in the Osteogenesis of MC3T3-E1 Cells by JNK and p38-MAPK Pathways
por: Xie, Baocheng, et al.
Publicado: (2021) -
Rubidium Chloride Targets Jnk/p38-Mediated NF-κB Activation to Attenuate Osteoclastogenesis and Facilitate Osteoblastogenesis
por: Ouyang, Zhengxiao, et al.
Publicado: (2019)